Loss of the inactive X chromosome and replication of the active X in BRCA1-defective and wild-type breast cancer cells

Cancer Research

Volumn 65, Issue 6, 2005, Pages 2139-2146

  Sirchia, Silvia M ^a,b   Ramoscelli, Lisetta ^a   Grati, Francesca R ^a   Barbera, Floriana ^c,d   Coradini, Danila ^c   Rossella, Franca ^a   Porta, Giovanni ^e   Lesma, Elena ^b   Ruggeri, Anna ^f   Radice, Paolo ^c,d   Simoni, Giuseppe ^a   Miozzo, Monica ^a  

^a Laboratorio di Informatica Medica   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c NATIONAL CANCER INSTITUTE   (Italy)

^d Ist Fondazione Italiana Ric C   (Italy)

^e UNIVERSITY OF INSUBRIA   (Italy)

^f Laboratorio TOMA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; HISTONE DEACETYLASE INHIBITOR;

ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER CELL CULTURE; CHROMOSOME LOSS; CHROMOSOME REPLICATION; CONTROLLED STUDY; EPIGENETICS; GENE EXPRESSION; GENE LOSS; GENE SILENCING; GENETIC ANALYSIS; GENETIC EPIGENESIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; WILD TYPE; X CHROMOSOME; X CHROMOSOME INACTIVATION;

BREAST NEOPLASMS; CELL LINE, TUMOR; CHROMATIN; CHROMOSOMES, HUMAN, X; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENES, BRCA1; HOMOZYGOTE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; RNA, UNTRANSLATED; TRANSCRIPTION, GENETIC;

EID: 20144389742     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-3465     Document Type: Article

References (45)

1. Plath K, Mlynarczyk-Evans S, Nusinow DA, Panning B, Xist RNA and the mechanism of X chromosome inactivation [review]. Annu Rev Genet 2002;36:233-78.
2. Brown CJ, Ballabio A, Rupert JL, et al. A gene from the region of the human X inactivation centre is expressed exclusively from the inactive X chromosome Nature 1991;349:38-44.
3. Heard E, Rougeulle C, Arnaud D, Avner P, Allis CD, Spector DL. Methylation of histone H3 at Lys-9 is an early mark on the X chromosome during X inactivation. Cell 2001;107:727-38.
4. Csankovszki G, Nagy A, Jaenisch RJ. Synergism of Xist RNA, DNA methylation, and histone hypoacetylation in maintaining X chromosome inactivation. Cell Biol 2001;153:773-84.
5. Boggs BA, Cheung P, Heard E, et al. Differentially methylated forms of histone H3 show unique association patterns with inactive human X chromosomes. Nat Genet 2002;30:73-6.
6. Ganesan S, Silver DP, Greenberg RA, et al. BRCA1 supports XIST RNA concentration on the inactive X chromosome. Cell 2002;111:393-405.
7. Deng CX, Brodie SG. Roles of BRCA1 and its interacting proteins [review]. Bioessays 2000;22:728-37.
8. Scully R, Livingston DM. In search of the tumour-suppressor functions of BRCA1 and BRCA2. Nature 2000;408:429-32.
9. Kerr P, Ashworth A. New complexities for BRCA1 and BRCA2 [review]. Curr Biol 2001;11:R668-76.
10. Venkitaraman AR. Cancer susceptibility and the functions of BRCA1 and BRCA2 [review]. Cell 2002;108:171-82.
11. King MC, Marks JH, Mandell JB. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 2003;302:643-6.
12. Csankovszki G, Panning B, Bates B, Pehrson JR, Jaenisch R. Conditional deletion of Xist disrupts histone macroH2A. localization but not maintenance of X inactivation. Nat Genet 1999;22:323-4.
13. Kimel VM. Clinical-cytological correlations of mammary carcinoma based upon sex-chromatin counts; a preliminary study. Cancer 1957;10:922-7.
14. Moore KL, Barr ML. The sex chromatin in human malignant tissues. Br J Cancer 1957;11:384-90.
15. Savino A, Koss LG. The evaluation of sex chromatin as a prognostic factor in carcinoma of the breast. A preliminary report. Acta Cytol 1971;15:372-4.
16. Perry M. Evaluation of breast tumour sex chromatin (Barr body) as an index of survival and response to pituitary ablation. Br J Surg 1972;59:731-4.
17. Camargo M, Wang N. Cytogenetic evidence for the absence of an inactivated X chromosome in a human female (XX) breast carcinoma cell line. Hum Genet 1980;55:81-5.
18. Dutrillaux B, Muleris M, Seureau MG. Imbalance of sex chromosomes, with gain of early-replicating X, in human solid tumors. Int J Cancer 1986;38:475-9.
19. Wang N, Cedrone E, Skuse GR, Insel R, Dry J. Two identical active X chromosomes in human mammary carcinoma cells. Cancer Genet Cytogenet 1990;46:271-80.
20. Giammarini A, Rocchi M, Zennaro W, Filippi G. XX male with breast cancer. Clin Genet 1980;18:103-8.
21. Balazs M, Mayall BH, Waldman FM. Simultaneous analysis of chromosomal aneusomy and 5-bromodeoxyuridine incorporation in MCF-7 breast tumor cell line. Cancer Genet Cytogenet 1991;57:93-102.
22. Wolman SR, Sanford J, Ratner S, Dawson PJ. Breast cancer in males: DNA content and sex chromosome constitution. Mod Pathol 1995;8:239-43.
23. Teixeira MR, Pandis N, Dietrich CU et al. Chromosome banding analysis of gynecomastias and breast carcinomas in men. Genes Chromosomes Cancer 1998;23:16-20.
24. Rudas M, Schmidinger M, Wenzel C, et al. Karyotypic findings in two cases of male breast cancer. Cancer Genet Cytogenet 2000;121:190-3.
25. Swerdlow AJ, Hermon C, Jacobs PA, et al. Mortality and cancer incidence in persons with numerical sex chromosome abnormalities: a cohort study. Ann Hum Genet 2001;65:177-88.
26. Giordano SH, Buzdar AU, Hortobagyi GN. Breast cancer in men [review]. Ann Intern Med 2002;137:678-87.
27. Wagner TM, Moslinger RA, Muhr D, et al. BRCA1-related breast cancer in Austrian breast and ovarian cancer families: specific BRCA1 mutations and pathological characteristics. Int J Cancer 1998;77:354-60.
28. De Benedetti VM, Radice P, Mondini P, et al. Characterization of ten novel and 13 recurring BRCA1 and BRCA2 germline mutations in Italian breast and/or ovarian carcinoma patients. Oncogene 1996;13:1353-7.
29. Brown CJ, Hendrich BD, Rupert JL, et al. The human XIST gene: analysis of a 17 kb inactive X-specific RNA that contains conserved repeats and is highly localized within the nucleus. Cell 1992;71:527-42.
30. Fehm T, Morrison L, Saboorian H, et al. Patterns of aneusomy for three chromosomes in individual cells from breast cancer tumors. Breast Cancer Res Treat 2002;75:227-39.
31. Allen RC, Zoghbi HY, Moseley AB, Rosenblatt HM, Belmont JW. Methylation of HpalI and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am J Hum Genet 1992;51:1229-39.
32. Gilbert SL, Sharp PA. Promoter-specific hypoacetylation of X-inactivated genes. Proc Natl Acad Sci U S A 1999;96:13825-30.
33. Xiong Z, Laird PW. COBRA: a sensitive and quantitative DNA methylation assay. Nucleic Acids Res 1997;25:2532-4.
34. Tomlinson GE, Chen TT, Stastny VA, et al. Characterization of a breast cancer cell line derived from a germ-line BRCA1 mutation carrier. Cancer Res 1998;58:3237-42.
35. Canzian F, Salovaara R, Hemminki A, et al. Semiautomated assessment of loss of heterozygosity and replication error in tumors. Cancer Res 1996;56:3331-7.
36. Lachner M, Jenuwein T. The many faces of histone lysine methylation [review]. Curr Opin Cell Biol 2002;14:286-98.
37. Peters AH, Mermoud JZ, O'Carroll D, et al. Histone H3 lysine 9 methylation is an epigenetic imprint of facultative heterochromatin. Nat Genet 2002;30:77-80.
38. Hendrich BD, Brown CJ, Willard HF. Evolutionary conservation of possible functional domains of the human and murine XIST genes. Hum Mol Genet 1993;2:663-72.
39. Loupart ML, Adams S, Armour JA, Walker R, Brammar W, Varley J. Loss of heterozygosity on the X chromosome in human breast cancer. Genes Chromosomes Cancer 1995;13:229-38.
40. Choi C, Kim MH, Juhng SW. Loss of heterozygosity on chromosome Xp22.2-p22.13 and Xq26.1-q27.1 in human breast carcinomas. J Korean Med Sci 1998;13:311-6.
41. Piao Z, Malkhosyan SR. Frequent loss Xq25 on the inactive X chromosome in primary breast carcinomas is associated with tumor grade and axillary lymphonode metastasis. Genes Chromosomes Cancer 2002;33:262-9.
42. Roncuzzi L, Brognara I, Cocchi S, Zoli W, Gasperi-Campani A. Loss of heterozygosity at pseudoautosomal regions in human breast cancer and association with negative hormonal phenotype. Cancer Genet Cytogenet 2002;135:173-6.
43. Holt JT, Thompson ME, Szabo C, et al. Growth retardation and tumour inhibition by BRCA1. Nat Genet 1996;12:298-302.
44. Favy DA, Rio P, Maurizis JC, Hizel C, Bignon YJ, Bernard-Gallon DJ. Prolactin-dependent up-regulation of BRCA1 expression in human breast cancer cell lines. Biochem Biophys Res Commun 1999;258:284-91.
45. Avner P, Heard, E. X-chromosome inactivation: counting, choice and initiation. Nat Rev Genet 2001;2:59-67.